Drugs / ex-vivo gene-therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01906541 | Jul → Dec 2013 | granulomatous disease, chronic, X-linked | Hubert Serve, Prof., MD | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ex-vivo gene-therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01906541 ↗ |
| Modality | Cell therapy | “transplantation of genetically modified autologous CD34+ cells” NCT01906541 ↗ |